Bacterial antimicrobial resistance (AMR) contributed to 4.95 million deaths worldwide in 2019, making it one of the top global public health and development threats today according to the World Health Organisation.
At the ground-breaking Antimicrobial Stewardship Center of Excellence Symposium held in Kula Lumpur on 22 November, IHH Malaysia and our Premier Integrated Labs joined forces with bioMérieux, to drive industry collaboration in tackling AMR.
The symposium highlighted the importance of diagnostics in AMR control, the link between AMR and judicious use of antibiotics, and initiatives in the public and private healthcare sector for controlling AMR.
Jean-François Naa, CEO of IHH Healthcare Malaysia, expressed his commitment, stating, "At IHH Healthcare Malaysia, combating AMR is ingrained in our global sustainability goals. Our active AMS committee strategically spearheads initiatives. In this battle, knowledge is our strongest ally. The exchange of insights between global experts, local healthcare leaders, and private providers is crucial as we navigate uncharted waters. Moving forward, strategic collaboration is paramount to combat resistance instead of working in silos."
Related Stories
People-led Innovation Driving Impact Across IHH Healthcare
Gleneagles Hospital Hong Kong Highlights Healthcare at ITB China 2026
Travel today is no longer defined by destinations alone — it is shaped by the confidence and assurance travellers carry with them.
Gleneagles Hospital Hong Kong Delivers Seamless Musculoskeletal Care
Gleneagles Hospital Hong Kong is strengthening musculoskeletal (MSK) care through closer collaboration, bringing together insurers and healthcare providers to support a more connected and patient-centred treatment journey.
IHH Healthcare Singapore Recognised for Building Meaningful Employee Experiences
Gleneagles Hospital Singapore showcased Enhanced Recovery After Surgery (ERAS®) programme at 12th ERAS® World Congress
Gleneagles Hospital Singapore is advancing surgical recovery through its adoption of the Enhanced Recovery After Surgery (ERAS®) programme, recognised for its early implementation in Singapore’s private healthcare sector.
